Merz North America, Inc., a prominent player in the healthcare and aesthetics industry, is headquartered in the United States. Founded in 1908, the company has established itself as a leader in innovative solutions for medical aesthetics, dermatology, and neurology. With a strong presence across North America, Merz North America focuses on delivering high-quality products and services that enhance patient outcomes and improve quality of life. The company’s core offerings include advanced injectables, skincare products, and devices that stand out for their efficacy and safety. Notable achievements include the successful launch of several flagship products that have set new standards in the industry. Merz North America continues to solidify its market position through a commitment to research and development, ensuring it remains at the forefront of aesthetic and therapeutic advancements.
How does Merz North America, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Merz North America, Inc.'s score of 29 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merz North America, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Merz Pharma GmbH & Co. KGaA, which may influence its climate commitments and emissions reporting. As of now, Merz North America has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi). Additionally, there are no climate pledges or initiatives reported that would indicate a proactive stance towards reducing carbon emissions. Given the lack of specific emissions data and reduction initiatives, it is essential to note that Merz North America may be aligning its climate strategies with those of its parent company, Merz Pharma GmbH & Co. KGaA, which could potentially have its own emissions targets and sustainability commitments. However, without explicit data or targets from Merz North America, the details remain vague.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 2,088,000 | 0,000,000 |
| Scope 2 | 771,000 | 000,000 |
| Scope 3 | 36,782,000 | 00,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Merz North America, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

